|
Volumn 19, Issue SUPPL. 2, 2001, Pages 49-52
|
Using health outcomes data to inform decision-making: Formulary committee perspective
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN ANTAGONIST;
ANTIBIOTIC AGENT;
ANTIDEPRESSANT AGENT;
ANTIEMETIC AGENT;
BRONCHODILATING AGENT;
CALCIUM ANTAGONIST;
CARBAPENEM DERIVATIVE;
CONTRAST MEDIUM;
CORTICOSTEROID;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GLYCOPEPTIDE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW MOLECULAR WEIGHT HEPARIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
BRONCHITIS;
COMPUTER PROGRAM;
CONFERENCE PAPER;
CYSTITIS;
DECISION MAKING;
DRUG FORMULARY;
DRUG SELECTIVITY;
ECONOMIC EVALUATION;
EVIDENCE BASED MEDICINE;
FINANCIAL MANAGEMENT;
HEALTH CARE ORGANIZATION;
HEALTH ECONOMICS;
HUMAN;
NEUTROPENIA;
OUTCOMES RESEARCH;
PNEUMONIA;
PRIORITY JOURNAL;
RESOURCE ALLOCATION;
|
EID: 0034787416
PISSN: 11707690
EISSN: None
Source Type: Journal
DOI: 10.2165/00019053-200119002-00008 Document Type: Conference Paper |
Times cited : (6)
|
References (22)
|